About

History

2022
Jan
License with Harvard University for manufacturing bacterial strains
Mar
Designated as Gwangju Global IP Star Company
Apr
Grant for Industry-University R&D Collaboration Project from the Korean government
Apr
Grant for Gwangju INNOPOLIS R&D commercialization project from the Korean government
2021
Jan
Patent application of delivery platform technology for therapeutic proteins
Mar
Contract with Quratis for PAT101 production
Jul
Contract with Charles River for PAT101
Jul
Non-clinical study
Oct
Series A-1 fund raising
Nov
Supply Agreement for rHSA with Albumedix Ltd.
Nov
Awarded as an excellent IP-R&D Institution by the government
2020
Jun
PCT patent application of alburicase
Aug
Series A capital increase
Sep
Establishment of Seoul R&D center
Oct
Establishment of Seoul branch (Central Research Center)
Dec
Commendation from the mayor of Gwangju (revitalization of local venture companies)
2019
Jun
Seed capital increase
Oct
Patent application of alburicase
2018
May
Certificate of venture company from the Korean government
2017
Sep
Founded ProAbTech
Dec
Seed capital increase

EN